BioSpace News Archive

PCLX-001 is the first clinical candidate sponsored by Pacylex Pharmaceuticals to reach the clinical stage

Hanger, Inc. announced today that members of its management team will participate virtually in presentations and meetings with institutional investors at the Baird 2021 Global Healthcare Conference taking place September 14-15, 2021.

Cantex Pharmaceuticals, Inc. (“Cantex”) today announced that it has sold 6.5 million shares of Chimerix, Inc.

Cairn Diagnostics, an innovative leader in providing cutting-edge breath tests intended for routine use in diagnostic medicine, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approval of the Company’s 13C-Spirulina Gastric Emptying Breath Test (GEBT) to now include “at home” administration under virtual supervision of Cairn Diagnostics.

Biotricity Inc. today announced that it has developed a personal medical device kit, Biokit, a bundled home-use set comprised of a digital thermometer, a pulse oximeter, and a blood pressure cuff.

Peijia Medical today announced the initiation of its multi-center clinical trial for TaurusNXT ® , the third-generation transcatheter aortic valve (“TAVR”) system, following the first successful patient implant in Zhongshan Hospital of Fudan University.

Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors.

City of Hope is now enrolling patients in a Phase 2 clinical trial of its COH04S1 vaccine

A new study by researchers from the Gwangju Institute of Science and Technology in the Republic of Korea has revealed the mechanism of DNA repair by enzymes exonuclease III and polymerase I by utilizing single molecule fluorescence resonance energy transfer -enabled dynamic observation.

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced that management will present and participate at multiple virtual investor conferences in September 2021.